Healthcare · Pharmaceutical expenditure
Libya's pharmaceutical expenditure stands at 1.20 % GDP of GDP in 2026, a figure close to the global average. Most spending goes toward imported medicines, as the domestic pharmaceutical industry remains underdeveloped — only a few generic drug factories operate, meeting less than 15% of national demand. This heavy reliance on foreign suppliers makes the system vulnerable to currency fluctuations and supply chain disruptions. Among 197 countries, Libya ranks 92.
Data for 2026 · unit: % GDP
Position
#92 / 197
Libya world ranking
Country position on the scale from last to first place for this indicator.
LY
#92
#197#1
Trend
Change over time
Change in indicator over the available period.
0.80
1990
1.00
2000
1.30
2010
1.10
2020
1.20
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Libya stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Libya — how much?
Based on 2026 data — 1.20 % GDP. This is rank #92 out of 197 countries.
What is Libya's rank by Pharmaceutical expenditure?
Libya ranks #92 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Libya?
Over the available period the indicator changed from 0.80 to 1.20 % GDP.